Tevogen Bio Stock (NASDAQ:TVGN)
Previous Close
$0.72
52W Range
$0.64 - $3.09
50D Avg
$0.84
200D Avg
$1.11
Market Cap
$138.01M
Avg Vol (3M)
$835.41K
Beta
-0.81
Div Yield
-
TVGN Company Profile
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.